SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000929638-22-000604
Filing Date
2022-03-14
Accepted
2022-03-14 09:29:20
Documents
1
Group Members
AQUILA INVESTMENTS IVTYBOURNE CAPITAL MANAGEMENT LTDTYBOURNE KESARI LTDVISWANATHAN KRISHNAN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 schedule13da.htm SC 13D/A 101878
  Complete submission text file 0000929638-22-000604.txt   103726
Mailing Address 30/F, AIA CENTRAL 1 CONNAUGHT ROAD C HONG KONG K3 XXXXX
Business Address 30/F, AIA CENTRAL 1 CONNAUGHT ROAD C HONG KONG K3 XXXXX 852-3983-6869
TYBOURNE CAPITAL MANAGEMENT (HK) LTD (Filed by) CIK: 0001553936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address B900 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 011441223261503
BICYCLE THERAPEUTICS plc (Subject) CIK: 0001761612 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A | Act: 34 | File No.: 005-91023 | Film No.: 22735271
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences